Lyphe Australia exits clinic sector, axes MSL team, but sets new course for product growth by Steve Jones August 29, 2024August 29, 2024 Lyphe Australia has sold its clinic business and made its three-strong Medical Science Liaison (MSL) team […]
Lyphe Australia MD Tracey Loton to go it alone after exiting business by Steve Jones March 6, 2024March 6, 2024
Lyphe Australia ‘unaffected’ despite UK parent entering administration by Steve Jones December 14, 2023December 14, 2023
Trademark row brews as Cannatrek looks to monopolise ‘T’ branding by Steve Jones June 7, 2023April 30, 2024
Lyphe Group ramps up local operation with plans to replicate UK success in Australia by Martin Lane March 27, 2023April 30, 2024
Company news: Eqalis/Novachem; Cann Group; Vitura Health; Incannex; Lyphe Group by Steve Jones and Martin Lane March 1, 2023April 30, 2024
Cann Group COO: ‘we need to put our big boy pants on and adopt a pharmaceutical mindset’ by Steve Jones February 25, 2021April 26, 2024
Cann Group ships first batch of medicinal cannabis oil to the UK by Martin Lane December 23, 2020April 26, 2024
Cannatrek releases first products in Australia and signs export agreement with the UK by Emma Castle October 13, 2020April 26, 2024
